Theralase Technologies Inc.
TLTFF
Price:
$0.112
Market Cap:
$39.84M
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II for the treatment of Bacillus Calmette Guérin - Unresponsive Carcinoma In-Situ non-muscle invasive bladder cancer. Further, its produc...[Read more]
Industry
Medical - Devices
IPO Date
2010-04-05
Stock Exchange
OTC
Ticker
TLTFF
PE Ratio
[-11.20]
ROE
[-260.39%]
Current Ratio
[0.96]
Dividend Yield
[0%]
Enterprise Value
[40.04M]
Dividend History
The ROE as of December 2025 (TTM) for Theralase Technologies Inc. (TLTFF) is -260.39%
According to Theralase Technologies Inc.’s latest financial reports and current stock price. The company's current ROE is -260.39%. This represents a change of 249.78% compared to the average of -74.44% of the last 4 quarters.
Theralase Technologies Inc. (TLTFF) Historical ROE (quarterly & annually)
How has TLTFF ROE performed in the past?
The mean historical ROE of Theralase Technologies Inc. over the last ten years is -162.03%. The current -260.39% ROE has changed 60.70% with respect to the historical average. Over the past ten years (40 quarters), TLTFF's ROE was at its highest in in the December 2020 quarter at -9.63%. The ROE was at its lowest in in the March 2025 quarter at -134.95%.
Average
-162.03%
Median
-128.41%
Minimum
-336.15%
Maximum
-53.60%
Theralase Technologies Inc. (TLTFF) ROE by Quarter and Year
Discovering the peaks and valleys of Theralase Technologies Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 244.49%
Maximum Annual ROE = -53.60%
Minimum Annual Increase = -84.06%
Minimum Annual ROE = -336.15%
| Year | ROE | Change |
|---|---|---|
| 2024 | -205.86% | -14.18% |
| 2023 | -239.89% | 41.35% |
| 2022 | -169.71% | 94.84% |
| 2021 | -87.11% | 42.33% |
| 2020 | -61.20% | 14.18% |
| 2019 | -53.60% | -84.06% |
| 2018 | -336.15% | 12.84% |
| 2017 | -297.89% | 244.49% |
| 2016 | -86.47% | 4.88% |
| 2015 | -82.45% | 5.33% |
Theralase Technologies Inc. (TLTFF) Average ROE
How has TLTFF ROE performed in the past?
The current ROE of Theralase Technologies Inc. (TLTFF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-205.15%
5-year avg
-152.75%
10-year avg
-162.03%
Theralase Technologies Inc. (TLTFF) ROE vs. Peers
How is TLTFF’s ROE compared to its peers?
Theralase Technologies Inc.’s ROE is greater than Vivos Inc. (-144.60%), greater than Novacyt S.A. (-61.81%), less than Drug Free Solution, Inc. (2.58%), greater than Nova Eye Medical Limited (-49.85%), greater than Cynata Therapeutics Limited (-107.51%), less than MedMira Inc. (23.46%), less than Sernova Corp. (137.16%), greater than Bioqual, Inc. (-2.90%), greater than PetVivo Holdings, Inc. (-332.05%), less than Medical Developments International Limited (0.17%),
| Company | ROE | Market cap |
|---|---|---|
| -144.60% | $33.04M | |
| -61.81% | $36.02M | |
| 2.58% | $488.90K | |
| -49.85% | $28.48M | |
| -107.51% | $35.62M | |
| 23.46% | $15.51M | |
| 137.16% | $33.36M | |
| -2.90% | $34.44M | |
| -332.05% | $26.03M | |
| 0.17% | $36.12M |
Build a custom stock screener for Theralase Technologies Inc. (TLTFF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralase Technologies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Theralase Technologies Inc. (TLTFF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Theralase Technologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Theralase Technologies Inc.'s ROE?
How is the ROE calculated for Theralase Technologies Inc. (TLTFF)?
What is the highest ROE for Theralase Technologies Inc. (TLTFF)?
What is the 3-year average ROE for Theralase Technologies Inc. (TLTFF)?
What is the 5-year average ROE for Theralase Technologies Inc. (TLTFF)?
How does the current ROE for Theralase Technologies Inc. (TLTFF) compare to its historical average?